CA2850089A1 - Stable dosage forms of arterolane and piperaquine - Google Patents

Stable dosage forms of arterolane and piperaquine Download PDF

Info

Publication number
CA2850089A1
CA2850089A1 CA2850089A CA2850089A CA2850089A1 CA 2850089 A1 CA2850089 A1 CA 2850089A1 CA 2850089 A CA2850089 A CA 2850089A CA 2850089 A CA2850089 A CA 2850089A CA 2850089 A1 CA2850089 A1 CA 2850089A1
Authority
CA
Canada
Prior art keywords
dosage form
active compound
piperaquine
solid oral
stable solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2850089A
Other languages
English (en)
French (fr)
Inventor
Arno Appavoo Enose
Harish Kumar Madan
Sumit Madan
Anupam Trehan
Puneet Tyagi
Vinod Kumar Arora
Arjun Roy
Annamdevara Balaji
Sanjukta Bhattacharyya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/183,119 external-priority patent/US8664265B2/en
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of CA2850089A1 publication Critical patent/CA2850089A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA2850089A 2011-07-14 2012-07-13 Stable dosage forms of arterolane and piperaquine Abandoned CA2850089A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US13/183,119 2011-07-14
US13/183,119 US8664265B2 (en) 2005-05-18 2011-07-14 Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
IN2703/DEL/2011 2011-09-19
IN2703DE2011 2011-09-19
IN2156/DEL/2012 2012-07-12
IN2156DE2012 2012-07-12
PCT/IB2012/053614 WO2013008218A1 (en) 2011-07-14 2012-07-13 Stable dosage forms of arterolane and piperaquine

Publications (1)

Publication Number Publication Date
CA2850089A1 true CA2850089A1 (en) 2013-01-17

Family

ID=47505579

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2850089A Abandoned CA2850089A1 (en) 2011-07-14 2012-07-13 Stable dosage forms of arterolane and piperaquine

Country Status (10)

Country Link
EP (1) EP2731603A1 (ko)
JP (1) JP2014522856A (ko)
KR (1) KR20140053169A (ko)
CN (1) CN103930107A (ko)
AP (1) AP2014007413A0 (ko)
AU (1) AU2012282077A1 (ko)
CA (1) CA2850089A1 (ko)
EA (1) EA201490233A8 (ko)
MX (1) MX2014000463A (ko)
WO (1) WO2013008218A1 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014132226A1 (en) 2013-02-28 2014-09-04 Ranbaxy Laboratories Limited Stable dispersible formulation of arterolane maleate and piperaquine and process of preparation thereof
KR101698003B1 (ko) * 2016-06-20 2017-01-19 여오영 퀴닌 염 현탁액을 포함하는 항암 치료를 위한 국소 투여용 주사제 조성물
CA3083683A1 (en) * 2017-12-12 2019-06-20 Intervet International B.V. Implantable isoxazoline pharmaceutical compositions and uses thereof
EP4196115A1 (en) * 2020-08-14 2023-06-21 Sun Pharmaceutical Industries Limited Fixed dose combination drug for the treatment of malaria

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486199B1 (en) 2001-06-21 2002-11-26 Medicines For Malaria Venture Mmv International Centre Cointrin Spiro and dispiro 1,2,4-trioxolane antimalarials
US6825230B2 (en) 2002-06-21 2004-11-30 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trixolane antimalarials
US6906205B2 (en) 2002-06-21 2005-06-14 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US20090042821A1 (en) * 2005-05-18 2009-02-12 Arno Appavoo Enose Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
CN101472582A (zh) * 2006-05-17 2009-07-01 兰贝克赛实验室有限公司 联用合成青蒿素衍生物和双喹啉衍生物的抗疟疗法

Also Published As

Publication number Publication date
KR20140053169A (ko) 2014-05-07
AP2014007413A0 (en) 2014-02-28
AU2012282077A1 (en) 2014-01-30
MX2014000463A (es) 2014-07-09
EA201490233A1 (ru) 2014-07-30
WO2013008218A1 (en) 2013-01-17
JP2014522856A (ja) 2014-09-08
EA201490233A8 (ru) 2015-01-30
CN103930107A (zh) 2014-07-16
AP3777A (ko) 2016-08-31
EP2731603A1 (en) 2014-05-21

Similar Documents

Publication Publication Date Title
US8664265B2 (en) Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
JP4803686B2 (ja) 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠
EP2276465B1 (en) Extended release formulation containing a wax
KR101378973B1 (ko) 구형에 가까운 형태의 다중 투여 단위 정제를 포함하는 경질 캡슐 복합 제형 및 이의 제조방법
KR102072546B1 (ko) 레날리도마이드의 경구용 정제 조성물
KR20120034630A (ko) 고용량 및 저용량 약물들의 조합을 포함하는 구강붕해정 조성물
JP6288158B2 (ja) 品質が向上した経口製剤
US5814339A (en) Film coated tablet of paracetamol and domperidone
AU2012340759A1 (en) Pharmaceutical formulations
KR101828630B1 (ko) 구강 내 붕괴 정제
CA2850089A1 (en) Stable dosage forms of arterolane and piperaquine
WO2005023304A2 (en) Antimalarial compositions and manufacturing process thereof
EP2698150A1 (en) Oral solid preparation of compound antituberculosis drug and preparation method thereof
RU2694056C2 (ru) Противотуберкулезная стабильная фармацевтическая композиция в форме диспергируемой таблетки, содержащей гранулированный изониазид и гранулированный рифапентин, и способ ее приготовления
KR20140081826A (ko) 서방성 제제
EP3496719B1 (en) A multi-class anti-retroviral composition
WO2007017646A2 (en) Anti-malarial composition comprising artesunate and lumefantrine
WO2008068778A2 (en) Extended release pharmaceutical composition of pramipexole
KR102127625B1 (ko) 하이드로모르폰염산염 함유의 경구용 서방성 의약 조성물
EP3854386A1 (en) An orally disintegrating pharmaceutical composition comprising nefopam and process for preparing the same
OA16845A (en) Stable dosage forms of arterolane and piperaquine
WO2014132226A1 (en) Stable dispersible formulation of arterolane maleate and piperaquine and process of preparation thereof
KR20190129880A (ko) 날푸라핀을 함유하는 정제화된 의약 조성물
WO2022074681A1 (en) Pharmaceutical compositions with enhanced blend uniformity and content uniformity
KR100212960B1 (ko) 경구용 복합제제

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140114

FZDE Dead

Effective date: 20160928